A Randomized, Double-Blind, Multicenter, Controlled Clinical Trial of Cyclosporine Plus Chloroquine vs. Cyclosporine Plus Placebo in Early-Onset Rheumatoid Arthritis
✍ Scribed by Juan M Miranda; José Alvarez-Nemegyei; Miguel A Saavedra; Leobardo Terán; Federico Galván-Villegas; José Garcı́a-Figueroa; Luis J Jara; Leonor Barile; The GRECIA Group
- Book ID
- 113466612
- Publisher
- Elsevier Science
- Year
- 2004
- Tongue
- English
- Weight
- 110 KB
- Volume
- 35
- Category
- Article
- ISSN
- 0188-4409
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Because of its ability to decrease portal pressure, azygos blood flow, and postprandial splanchnic hyperemia, octreotide administration could be effective in reducing early rebleeding in patients undergoing endoscopic variceal sclerotherapy (EVS). We report the results of a trial comparing EVS + oct
## Abstract ## Objective To investigate the relationship between serum concentrations of infliximab, a monoclonal anti–tumor necrosis factor α antibody, and clinical improvement from infliximab therapy for rheumatoid arthritis (RA). ## Methods Multiple blood samples were obtained from each of 42